Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer

Ads

You May Also Like

Stemline Therapeutics Announces Proposed Public Offering of Common Stock

NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

MacroGenics to Participate in Three Investor Conferences in September

ROCKVILLE, MD, Aug. 30, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

ZIOPHARM Reports Fourth-Quarter 2015 Financial Results and Provides Update on Recent Activities

BOSTON, Feb. 24, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial ...